Adaptimmune Therapeutics PLC (ADAPY) Raw Materials (2024 - 2025)
Adaptimmune Therapeutics (ADAPY) reported Raw Materials of $10.76 million for Q2 2025, down 5.5% from the prior quarter.
Powered by 
Analysis
Adaptimmune Therapeutics PLC (ADAPY) Raw Materials (2024 - 2025) Analysis & Trends
At the end of FY2024, Adaptimmune Therapeutics posted Raw Materials of $7.24 million.
- Five-year quarterly Raw Materials spans a low of $1.74 million in Q3 2024 and a high of $11.38 million in Q1 2025.
- Per Business Quant data, the three quarters before Q2 2025 came in at $11.38 million (Q1 2025), $7.24 million (Q4 2024) and $1.74 million (Q3 2024).
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 10.76 Mn |
| Mar 31, 2025 | 11.38 Mn |
| Dec 31, 2024 | 7.24 Mn |
| Sep 30, 2024 | 1.74 Mn |
API Access
Adaptimmune Therapeutics PLC Raw Materials API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=raw-materials&ticker=ADAPY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "raw-materials", "ticker": "ADAPY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=raw-materials&ticker=ADAPY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();